IBDEI1YC ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34635,1,3,0)
 ;;=3^Acute Lymphangitis,Unspec
 ;;^UTILITY(U,$J,358.3,34635,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,34635,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,34636,0)
 ;;=L23.9^^192^2006^3
 ;;^UTILITY(U,$J,358.3,34636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34636,1,3,0)
 ;;=3^Allergic Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,34636,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,34636,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,34637,0)
 ;;=L03.90^^192^2006^4
 ;;^UTILITY(U,$J,358.3,34637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34637,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,34637,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,34637,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,34638,0)
 ;;=L02.91^^192^2006^7
 ;;^UTILITY(U,$J,358.3,34638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34638,1,3,0)
 ;;=3^Cutaneous Abscess,Unspec
 ;;^UTILITY(U,$J,358.3,34638,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,34638,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,34639,0)
 ;;=L30.2^^192^2006^8
 ;;^UTILITY(U,$J,358.3,34639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34639,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,34639,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,34639,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,34640,0)
 ;;=L30.9^^192^2006^10
 ;;^UTILITY(U,$J,358.3,34640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34640,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,34640,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,34640,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,34641,0)
 ;;=Z48.01^^192^2006^5
 ;;^UTILITY(U,$J,358.3,34641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34641,1,3,0)
 ;;=3^Change/Removal of Surgical Wound Dressing
 ;;^UTILITY(U,$J,358.3,34641,1,4,0)
 ;;=4^Z48.01
 ;;^UTILITY(U,$J,358.3,34641,2)
 ;;=^5063034
 ;;^UTILITY(U,$J,358.3,34642,0)
 ;;=L98.3^^192^2006^11
 ;;^UTILITY(U,$J,358.3,34642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34642,1,3,0)
 ;;=3^Eosinophilic Cellulitis
 ;;^UTILITY(U,$J,358.3,34642,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,34642,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,34643,0)
 ;;=L40.1^^192^2006^18
 ;;^UTILITY(U,$J,358.3,34643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34643,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,34643,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,34643,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,34644,0)
 ;;=L40.4^^192^2006^12
 ;;^UTILITY(U,$J,358.3,34644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34644,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,34644,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,34644,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,34645,0)
 ;;=L24.9^^192^2006^13
 ;;^UTILITY(U,$J,358.3,34645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34645,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,34645,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,34645,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,34646,0)
 ;;=L30.0^^192^2006^14
 ;;^UTILITY(U,$J,358.3,34646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34646,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,34646,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,34646,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,34647,0)
 ;;=L40.8^^192^2006^15
 ;;^UTILITY(U,$J,358.3,34647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34647,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,34647,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,34647,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,34648,0)
 ;;=L30.8^^192^2006^9
 ;;^UTILITY(U,$J,358.3,34648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34648,1,3,0)
 ;;=3^Dermatitis NEC
